Mark Pugh
Principal at Bly Associates | Seal Beach, California, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Executive Vice President at BakerCorp in January 2008 to Present
Principal at Bly Associates in March 2014 to Present
Vice President Europe Division at BakerCorp in January 2006 to January 2008
Vice President Operations at BakerCorp in January 2001 to January 2006
See more
See less
California State University, Chico
See more
See less
Contract Negotiation
Sales Management
Contract Management
Operations Management
New Business Development
Budgets
Negotiation
Procurement
Team Building
Purchasing
Account Management
Strategic Planning
Transportation
Logistics
Business Development
Management
See more
See less
What is Mark Pugh email address?
Email Mark Pugh at [email protected]. This email is the most updated Mark Pugh's email found in 2026.
How to contact Mark Pugh?
To contact Mark Pugh send an email to [email protected].
What company does Mark Pugh work for?
Mark Pugh works for Bly Associates
What is Mark Pugh's role at Bly Associates?
Mark Pugh is Principal
What is Mark Pugh's Phone Number?
Mark Pugh's phone (213) ***-*401
What industry does Mark Pugh work in?
Mark Pugh works in the Oil & Energy industry.
Mark Pugh Email Addresses
Mark Pugh Phone Numbers
Get a free list of similar prospects, filtered by title, company, or industry.
Build your Prospect ListPeople like Mark Pugh
Chairman & CEO/Owner, Andrews Logistics, Inc. at Andrews Logistics, LP
Entrepreneur / Investor at Acella Pharmaceuticals, LLC